Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017333
Filing Date
2019-05-08
Accepted
2019-05-08 17:17:10
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20190331.htm 10-Q 1610727
2 EX-10.1 ttph-ex101_13.htm EX-10.1 6312
3 EX-10.2 ttph-ex102_14.htm EX-10.2 49336
4 EX-31.1 ttph-ex311_6.htm EX-31.1 17278
5 EX-31.2 ttph-ex312_7.htm EX-31.2 17535
6 EX-32.1 ttph-ex321_8.htm EX-32.1 6201
7 EX-32.2 ttph-ex322_9.htm EX-32.2 6487
  Complete submission text file 0001564590-19-017333.txt   5357658

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ttph-20190331.xml EX-101.INS 895454
9 XBRL TAXONOMY EXTENSION SCHEMA ttph-20190331.xsd EX-101.SCH 51528
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20190331_cal.xml EX-101.CAL 43629
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20190331_def.xml EX-101.DEF 157034
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20190331_lab.xml EX-101.LAB 398829
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20190331_pre.xml EX-101.PRE 279636
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 19807712
SIC: 2834 Pharmaceutical Preparations